SEC 13F Intelligence

Dean Capital Management / MED

Dean Capital Management’s Medifast Inc Position

Does Dean Capital Management own Medifast Inc (MED)? Not currently — the last reported position was 12.0K shares worth $1M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q2 2023
Shares
12.0K
% of Portfolio
+1.48%
Quarters Held
3
position exited

Position History MED

Reported value by quarter
Q4 ’22: $348,011Q4 ’22Q1 ’23: $1MQ1 ’23Q2 ’23: $1MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202312.0K$1M+1.48%
Q1 202310.9K$1M+1.48%
Q4 20223.0K$348,011+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dean Capital Management’s full portfolio or all institutional holders of MED.